Sarah Dumont

2.2k total citations
64 papers, 783 citations indexed

About

Sarah Dumont is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Sarah Dumont has authored 64 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 29 papers in Oncology and 18 papers in Pathology and Forensic Medicine. Recurrent topics in Sarah Dumont's work include Sarcoma Diagnosis and Treatment (30 papers), Glioma Diagnosis and Treatment (9 papers) and Gastrointestinal Tumor Research and Treatment (9 papers). Sarah Dumont is often cited by papers focused on Sarcoma Diagnosis and Treatment (30 papers), Glioma Diagnosis and Treatment (9 papers) and Gastrointestinal Tumor Research and Treatment (9 papers). Sarah Dumont collaborates with scholars based in France, United States and Spain. Sarah Dumont's co-authors include Jonathan C. Trent, Amaury G. Dumont, Olivier Mir, Charles Honoré, Emmanuel Tiret, Alex Duval, Jean–François Fléjou, Christophe Louvet, Álvaro Coronado Muñoz and John M. Goldberg and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Annals of Oncology.

In The Last Decade

Sarah Dumont

60 papers receiving 778 citations

Peers

Sarah Dumont
Marie‐Pierre Sunyach France
Nicole Larrier United States
Angela Giardino United States
Dana L. Casey United States
Walid A. Mourad Saudi Arabia
Suman Malempati United States
Massimo Eraldo Abate Italy
Meltem Ekenel Türkiye
Siddharth Laskar India
Jochen Fleckenstein Germany
Marie‐Pierre Sunyach France
Sarah Dumont
Citations per year, relative to Sarah Dumont Sarah Dumont (= 1×) peers Marie‐Pierre Sunyach

Countries citing papers authored by Sarah Dumont

Since Specialization
Citations

This map shows the geographic impact of Sarah Dumont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Dumont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Dumont more than expected).

Fields of papers citing papers by Sarah Dumont

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Dumont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Dumont. The network helps show where Sarah Dumont may publish in the future.

Co-authorship network of co-authors of Sarah Dumont

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Dumont. A scholar is included among the top collaborators of Sarah Dumont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Dumont. Sarah Dumont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ammari, Samy, Tarek Assi, Mehdi Touat, et al.. (2021). Machine-Learning-Based Radiomics MRI Model for Survival Prediction of Recurrent Glioblastomas Treated with Bevacizumab. Diagnostics. 11(7). 1263–1263. 14 indexed citations
2.
Nassif, Elise F., Édouard Auclin, Rastilav Bahleda, et al.. (2021). TP53 Mutation as a Prognostic and Predictive Marker in Sarcoma: Pooled Analysis of MOSCATO and ProfiLER Precision Medicine Trials. Cancers. 13(13). 3362–3362. 7 indexed citations
3.
Honoré, Charles, Matthieu Faron, Andréa Cavalcanti, et al.. (2021). Prospective evaluation of intensity-modulated radiotherapy toxicity in extremity soft tissue sarcomas patients: A role for irradiated healthy soft tissue volume?. Clinical and Translational Radiation Oncology. 29. 79–84. 4 indexed citations
4.
Boilève, Alice, Armelle Dufresne, Ali N. Chamseddine, et al.. (2020). Outcomes of patients with metastatic gastrointestinal stromal tumors (GIST) treated with multi-kinase inhibitors other than imatinib as first-line treatment. ESMO Open. 5(6). e001082–e001082. 2 indexed citations
5.
6.
Blot, François, Sarah Dumont, Julien Rossignol, et al.. (2020). Ethical issues related to the COVID-19 pandemic in patients with cancer: experience and organisations in a French comprehensive cancer centre. BMJ Supportive & Palliative Care. 12(4). 413–420. 9 indexed citations
7.
Dumont, Sarah, et al.. (2020). Les tumeurs stromales gastro-intestinales sauvages. Bulletin du Cancer. 107(4). 499–505. 4 indexed citations
8.
Baldini, Capucine, P. Martin Romano, Andreea Varga, et al.. (2018). Immunothérapie des glioblastomes. Bulletin du Cancer. 105. S59–S67.
9.
Italiano, Antoîne, Valérie Laurence, Nicolas Penel, et al.. (2017). A Retrospective Multicentric Study of Ewing Sarcoma Family of Tumors in Patients Older Than 50: Management and Outcome. Scientific Reports. 7(1). 17917–17917. 8 indexed citations
10.
11.
Schernberg, Antoine, F. Dhermain, Samy Ammari, et al.. (2017). Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients. Cancer/Radiothérapie. 22(1). 9–16. 15 indexed citations
12.
Zanello, Marc, Mélanie Pagès, Arnault Tauziède‐Espariat, et al.. (2016). Clinical, Imaging, Histopathological and Molecular Characterization of Anaplastic Ganglioglioma. Journal of Neuropathology & Experimental Neurology. 75(10). 971–980. 34 indexed citations
13.
Graaf, Winette T.A. van der, et al.. (2016). Predictive factors for toxicity and survival of second line sunitinib in advanced gastrointestinal stromal tumours (GIST). Annals of Oncology. 27. vi490–vi490. 2 indexed citations
14.
Schernberg, Antoine, Aurélien Marabelle, Christophe Massard, et al.. (2016). Mise au point sur les glioblastomes : des thérapies ciblant les cellules tumorales aux thérapies ciblant les cellules immunitaires. Bulletin du Cancer. 103(5). 484–498. 5 indexed citations
15.
Dumont, Sarah, et al.. (2016). La coordination infirmière des adolescents et jeunes adultes en cancérologie. Soins Pédiatrie/Puériculture. 37(292). 44–47. 1 indexed citations
16.
Verret, Benjamin, Charles Honoré, Sarah Dumont, et al.. (2016). Trabectedin in advanced desmoplastic round cell tumors. Anti-Cancer Drugs. 28(1). 116–119. 9 indexed citations
17.
Dumont, Sarah, et al.. (2015). Le nab-paclitaxel. Bulletin du Cancer. 102(6). 568–576. 3 indexed citations
18.
Goldberg, John M., et al.. (2015). Rhabdomyosarcoma in Adults: New Perspectives on Therapy. Current Treatment Options in Oncology. 16(6). 27–27. 47 indexed citations
19.
Dumont, Sarah, Dan Yang, Agathe Dumont, et al.. (2014). Targeted polytherapy in small cell sarcoma and its association with doxorubicin. Molecular Oncology. 8(8). 1458–1468. 13 indexed citations
20.
Reynoso, David, Laura K. Nolden, Dan Yang, et al.. (2010). Synergistic induction of apoptosis by the Bcl‐2 inhibitor ABT‐737 and imatinib mesylate in gastrointestinal stromal tumor cells. Molecular Oncology. 5(1). 93–104. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie‐Pierre Sunyach Breakdown of academic impact, for papers by Nicole Larrier Breakdown of academic impact, for papers by Angela Giardino Breakdown of academic impact, for papers by Dana L. Casey Breakdown of academic impact, for papers by Walid A. Mourad Breakdown of academic impact, for papers by Suman Malempati Breakdown of academic impact, for papers by Massimo Eraldo Abate Breakdown of academic impact, for papers by Meltem Ekenel Breakdown of academic impact, for papers by Siddharth Laskar Breakdown of academic impact, for papers by Jochen Fleckenstein
Rankless by CCL
2026